ICMR teams up with Bharat Biotech to develop COVID-19 vaccine

The vaccine will be developed using the virus strain isolated at the ICMR's National Institute of Virology (NIV), Pune, a statement said. The strain has been successfully transferred from NIV to BBIL, it added. The death toll due to COVID-19 rose to 1,981 and the number of cases climbed to 59,662 in the country on Saturday, according to the Union Health Ministry.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2SPBLae
via IFTTT